Ossiam’s 10x Genomics TXG Stock Holding History

Ossiam’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.87M	Hold	229,300	–	–	0.09%	106
2025 Q4	$3.74M	Hold	229,300	–	–	0.07%	127
2025 Q3	$2.68M	Buy	+229,300	New	+$2.99M	0.03%	289

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ossiam's TXG Position: Q1 2026 in Review

Ossiam held its 10x Genomics (TXG) position steady in Q1 2026 at 229,300 shares worth $4.87M. The position accounts for 0.09% of the portfolio, ranked #106.

Ossiam first reported a position in TXG in Q3 2025 and has held it in 3 quarters since. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

Ossiam held 229,300 shares of 10x Genomics worth $4.87M as of Q1 2026.
Ossiam left its 10x Genomics share count unchanged in Q1 2026.
10x Genomics made up 0.09% of Ossiam's portfolio in Q1 2026, its #106 holding.
Ossiam first reported a position in 10x Genomics in Q3 2025 and has held it in 3 quarters since.
329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Ossiam's 13F filing for Q1 2026, filed 14 May 2026.